U.S. Markets closed

DiaSorin S.p.A. (DIA.MI)

Milan - Milan Delayed Price. Currency in EUR
Add to watchlist
71.55-0.15 (-0.21%)
At close: 5:35PM CEST

DiaSorin S.p.A.

Via Crescentino
Saluggia, VC 13040
39 01 614871

IndustryMedical Laboratories & Research
Full Time Employees1,913

Key Executives

Mr. Carlo RosaCEO, GM & Exec. DirectorN/AN/A51
Dr. Chen Menachem EvenChief Commercial Officer and Exec. DirectorN/AN/A54
Mr. Piergiorgio PedronChief Financial Officer and Sr. Corp. VPN/AN/A46
Riccardo FavaSr. Director of Investor Relations & Corp. CommunicationN/AN/AN/A
Mr. Marco MinolfoDirector of Corp. Legal Affairs Department and Standing Sec.N/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


DiaSorin S.p.A. engages in the development, production, and commercialization of diagnostic tests that are designed for hospital and private testing laboratories for use in various clinical areas in the market of immunodiagnostics and molecular diagnostics. The company offers immunodiagnostics products in the areas of infectious diseases; bone and mineral metabolism; endocrinology, including diabetes, thyroid function, fertility, growth, adrenal function, and gastroenterology; hypertension; oncology; gastrointestinal infections; autoimmunity; and cardiac and brain damages. Its immunodiagnostics systems include LIAISON XL, an automated chemiluminescence analyzer; LIAISON analyzer; ETI Max 3000, an automated microtiter plate analyzer; EVOlyzer 2-150/8 with disposable tips; and ELISA washers and readers. The company also offers molecular diagnostic products for oncology, hematology, and infectious diseases; systems, including LIAISON IXT and BULLET Pro to extract the nucleic acid from various biological samples; and LIAISON IAM to diagnose and monitor various infectious diseases and onco-hematology parameters. It sells its products directly, as well as through an international network of independent distributors in Europe, Africa, Central America, South America, the Asia Pacific, and North America. DiaSorin S.p.A. was founded in 1968 and is headquartered in Saluggia, Italy.

Corporate Governance

DiaSorin S.p.A.’s ISS Governance QualityScore as of August 1, 2017 is 7. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 6; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.